<--- Back to Details
First PageDocument Content
Pyridines / Rheumatoid arthritis / Oxicam / Health / Committee for Medicinal Products for Human Use / Non-steroidal anti-inflammatory drugs / Amides / Piroxicam
Date: 2015-02-25 08:39:55
Pyridines
Rheumatoid arthritis
Oxicam
Health
Committee for Medicinal Products for Human Use
Non-steroidal anti-inflammatory drugs
Amides
Piroxicam

Piroxicam 1. Chemical and Physical Characteristics Spectroscopy data

Add to Reading List

Source URL: www.iarc.fr

Download Document from Source Website

File Size: 2,20 MB

Share Document on Facebook

Similar Documents

Medical research / Clinical data management / Clinical research / Health / Pharmaceutical industry / Health informatics / Electronic common technical document / Pharmaceuticals policy / Marketing authorization / Committee for Medicinal Products for Human Use / Validation

PSUR Submissions in Single Assessment via EMA Gateway Webclient An agency of the European Union Presenters of the Day, from EMA

DocID: 1rf2q - View Document

Committee on Herbal Medicinal Products / Traditional medicine / European Directive on Traditional Herbal Medicinal Products / Committee for Medicinal Products for Human Use / Alternative medicine

ARTICLE IN PRESS Phytomedicine–250 www.elsevier.de/phymed ESCOP SECTION

DocID: 1qy48 - View Document

Health / Business / Pharmacology / Pharmaceuticals policy / European Medicines Agency / European Union / Committee for Medicinal Products for Human Use / Closure / Prescription drug / Packaging and labeling

Microsoft Word - Implementation Plan - QRD template_3

DocID: 1q3Qb - View Document

Research / Pharmaceutical industry / Pharmacy / Pharmacokinetics / Bioequivalence / European Medicines Agency / Committee for Medicinal Products for Human Use / Topical / Validation / Pharmaceutical sciences / Pharmacology / Clinical research

Concept Paper on Guideline on quality and equivalence of topical product - amended

DocID: 1giHZ - View Document

Research / Pharmacology / Biosimilar / Biotechnology / Drugs / Biologic / European Medicines Agency / Validation / Committee for Medicinal Products for Human Use / Pharmaceutical industry / Clinical research / Pharmaceutical sciences

Revised biosimilar quality guideline

DocID: 1g0Wz - View Document